PHENAZOPYRIDINE HYDROCHLORIDE

Product NDC
50090-3520
Requested package NDC
50090-3520-1
11-digit product format
500903520
Labeler code
50090
Product ID
50090-3520_2d811dd3-8e17-4979-aa7c-6e75d5b46773
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Phenazopyridine Hydrochloride
Dosage form
TABLET
Route
ORAL
Labeler
A-S Medication Solutions
Marketing category
UNAPPROVED DRUG OTHER
Marketing start
2015-03-05
Marketing end
0000-00-00
Substance
PHENAZOPYRIDINE HYDROCHLORIDE
Active strength
200 mg/1
NDC exclude flag
No
Listing certified through
2022-12-31
Current FDA listing
Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 1 matching rows.

Dataset, Scope, Product NDC table
DatasetScopeProduct NDCPackage NDCCodeStatusReporting periodSource date
excluded packagepackage50090-352050090-3520-1DDiscontinued by firm2026-11-19

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 2 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source dateDatasetScopeProduct NDCPackage NDCCodeStatusReporting periodArchiveSnapshotSource SHA-256
2025-12-14 17:58 UTC · source 2025-12-05excluded packagepackage50090-352050090-3520-1DDiscontinued by firmexcluded / ndc_excluded.zipd630ba8d3edf…732f749b63fb…
2025-08-27 00:01 UTC · source 2025-08-26excluded packagepackage50090-352050090-3520-1DDiscontinued by firmexcluded / ndc_excluded.zipf5e01cc5f278…a2eaf40c39c3…

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

FDA-Initiated Inactive NDC Indexing#

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
50090-3520-0EA - Each50090-352056965077-bdac-4ebf-9175-c40c4a21744212021-05-05
50090-3520-1EA - Each50090-3520b534a537-5e8f-4edb-8c32-32c59aba422112021-11-09
50090-3520-4EA - Each50090-3520186b734a-0d71-49d0-825e-f874eab5a6ee12021-11-09
50090-3520-6EA - Each50090-3520f5e4f4b5-3629-4ff8-92d6-60c6af9a6c0912021-11-09
50090-3520-7EA - Each50090-35206921474d-a5c2-4dcd-ba88-a326342b807012021-11-09

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
50090-3520PHENAZOPYRIDINE HYDROCHLORIDE TABLET [A-S MEDICATION SOLUTIONS]16Legacy NDC20230505_4c20ad22-48d7-4537-813a-7a7a46defeea.zip

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startMarketing endSampleExclude flagStatus
50090-3520-15009035200115 TABLET in 1 BOTTLE, PLASTIC (50090-3520-1) 15 tablet2015-03-050000-00-00NoNoCurrent